By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Marker Gene Technologies today announced a three-year, $1.6 million grant from the National Institutes of Health to further the company's screening technology directed at drugs for lysosomal storage disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.